SS
AGL icon

Steve Schonfeld’s Agilon Health AGL Stock Holding History

Steve Schonfeld’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Buy
+2,766
New +$181K ﹤0.01% 2043
2025
Q3 		– Sell
-29,594
Closed -$1.7M – 2166
2025
Q2 		$1.7M Buy
29,594
+9,472
+47% +$760K 0.01% 1067
2025
Q1 		$2.18M Buy
20,122
+16,582
+468% +$1.44M 0.01% 925
2024
Q4 		$168K Buy
3,540
+1,788
+102% +$108K ﹤0.01% 1787
2024
Q3 		$172K Buy
+1,752
New +$226K ﹤0.01% 1833
2024
Q2 		– Sell
-3,662
Closed -$558K – 2110
2024
Q1 		$558K Buy
+3,662
New +$609K ﹤0.01% 1442
2023
Q2 		– Sell
-1,649
Closed -$979K – 2092
2023
Q1 		$979K Sell
1,649
-1,504
-48% -$842K 0.01% 968
2022
Q4 		$1.27M Sell
3,153
-273
-8% -$128K 0.01% 1030
2022
Q3 		$2.01M Buy
+3,426
New +$2.05M 0.02% 858
2022
Q2 		– Sell
-800
Closed -$507K – 2489
2022
Q1 		$507K Buy
+800
New +$412K ﹤0.01% 1364
2021
Q3 		– Sell
-649
Closed -$659K – 2123
2021
Q2 		$659K Buy
+649
New +$569K 0.01% 1073

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Steve Schonfeld's AGL Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Agilon Health (AGL) in Q2 2026: 2,766 shares worth $296K. The stake represents ﹤0.01% of the portfolio and ranks #2043 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in AGL as recently as Q2 2025.

Steve Schonfeld first reported a position in AGL in Q2 2021 and has held it in 11 quarters since. The position peaked at $2.18M in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Steve Schonfeld held 2,766 shares of Agilon Health worth $296K as of Q2 2026.
  • Agilon Health was a new Steve Schonfeld position in Q2 2026.
  • Agilon Health made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2043 holding.
  • Steve Schonfeld first reported a position in Agilon Health in Q2 2021 and has held it in 11 quarters since.
  • Steve Schonfeld's Agilon Health position peaked at $2.18M in Q1 2025.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.